SynBioBeta Speaker

Andrea Stephany Diaz

OncoSwab

CEO & Founder

Andrea Stephany Díaz is a visionary entrepreneur and the Co-founder of OncoSwab. Selected as a top 100 young scientist in Europe, she stumbled upon a cancer screening idea that led her to start her first diagnostic company at the age of 24. Andrea pursued a Master’s degree in molecular biotechnology with a goal of making an impact in global health. Today, lung cancer is the leading cause of cancer death in the world, fueling Andrea's strategic vision for early detection with OncoSwab. Andrea brings a wealth of expertise and passion to these topics, making her an engaging and insightful guest for discussions on entrepreneurship, healthcare innovation, and the transformative potential of OncoSwab. Andrea is also committed to inspiring the next generation of young women in STEM through her YouTube channel, DNAndrea.

Sessions Featuring

Andrea Stephany

This Year

Femtech

•

12:45 PM

-

1:30 PM

Human Health

Early Detection. Precision Intervention. Real-World Deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

Featuring

Laura Glickman

Adjuvia

Co-Founder & CEO

Elizabeth Swenson

Teal Health

Medical Director

Viola Folli

D-Tails

Co-Founder & CSO

Andrea Stephany Diaz

OncoSwab

CEO & Founder

Zara Butte

Human Longevity

Physician

Femtech

•

12:45 PM

-

1:30 PM

Human Health

Early Detection. Precision Intervention. Real-World Deployment.

From circulating tumor DNA to AI-enabled diagnostics, liquid biopsies are collapsing the distance between biology and clinical action. This chamber convenes the scientists and clinicians leading that collapse — researchers who are not theorizing about the future of oncology, but building it: earlier signals, sharper targeting, smarter monitoring, and interventions that meet patients where the disease actually lives.

Featuring

Laura Glickman

Adjuvia

Co-Founder & CEO

Elizabeth Swenson

Teal Health

Medical Director

Viola Folli

D-Tails

Co-Founder & CSO

Andrea Stephany Diaz

OncoSwab

CEO & Founder

Zara Butte

Human Longevity

Physician

Previous Speakers Include